ft 23 mar 94 survey pharmaceut 6 disappoint polici document peter donnel examin whether european union help european drug compani european drug industri suitabl case treatment european union help european drug industri question echo around european capit come month provok polici document finalis earli march european commiss basi initi respons commiss paper echo may littl mute start 1994 seem rather late day address fundament question three decad attent legisl brussel strasbourg focus repeatedli differ aspect medicin market authoris patent extens drug promot cancer research sudden broad industri polici need say commiss sinc framework within pharmaceut compani oper profoundli shaken rise research develop cost emerg new technolog intern trend toward merger restructur secondli recommend commiss make fine nuanc cautiou titl commun outlin industri polici hesit conclus commiss make mani care genuflect mani differ direct document provid littl clear lead kind action discuss polici skate wide rang issu industri perform public health polici social secur spend research fund nation sovereignti subsidiar competit competit commiss fail offer effect resolut tension allud notabl cost contain research fund goe observ legitim concern limit public expenditur must allow jeopardis futur pharmaceut research europ prescrib littl anodyn intensif dialogu member state rang uninspir administr matter consolid exist legisl establish new european medicin agenc promot research co ordin surprisingli european drug compani danc street celebr new dawn high technolog medicin industri trade associ senior compani execut close involv evolut polici outlin mutter diplomat need studi document close judg point polit posit statement commiss incorpor valu industri europ economi citizen health may prove use vehicl dialogu develop industri polici conced chri dalton zeneca disguis intens disappoint felt throughout research base industri howev privat drug compani manag admit polici document contain much less hope wast opportun one remark sadli leaf document other voic fear unlik influenc produc chang talk defiantli polici outlin need lot work us compani europ alreadi write commiss express dissatisfact disappoint acut european drug industri felt earli 1994 go come exercis much stronger pro industri document follow 1991 undertak commission martin bangemann back industri battl better public understand select task forc drug industri expert hoechst glaxo rhone poulenc merck sharp amp dohm swiss firm work offici commiss industri affair servic 1993 bangemann auspic produc suitabl draft earli 1994 document readi chief import certainli industri address seriou concern research base drug compani nation control price reimburs go quit far drug firm want clearli recommend econom deregul free price new product phase gener price liberalis increas patient co payment move drug reimburs away polit control drug compani felt last given weapon battl discriminatori anti competit nation health polici quid pro quo liberalis addit stimul competit gener parallel import medicin spur compar inform doctor public drug drug price shortli full commiss ask endors bangemann draft document ambush loos coalit member state gener drug compani consum organis commiss servic felt rail road text reveal advanc stage draft nation health servic ask adapt need drug industri one outrag offici comment spearhead social affair commission padraig flynn also respons eu embryon health polici intens intra commiss hors trade exercis built new provis health employ social economi consider polici outlin reduc mere platitud nearli everyth industri tri care build result dilut satisfi one except member state retain almost uncondit autonomi prize manag health care budget includ drug price reimburs regim look handout deregul say ann polya pfizer plaintiv gener drug compani happi either greg perri european gener associ criticis lack provis gener compani prepar copi product last year product patent term copi launch immedi patent expiri without go real increas gener use say even consum find document ultim unhelp luc joossen brussel base consum spokesman health affair say vagu goe nowher hope clear commit increas incent gener prescrib dispens provid clear comprehens data drug consumpt optimist within commiss believ document still serv use purpos stimul inform discuss european parliament council industri minist twelv noth real substanc remov polici outlin accord fernand sauer commiss pharmaceut industri unit believ agenda set may lead nation govern take fresh look make asset drug industri repres europ brussel compet oblig member state act field discuss type may also induc voluntarili elimin distort function intern market